NAMI-A can directly inhibit the enzymatic activity of MMP-2 and MMP-9, as shown by the zymography performed with conditioned medium of fibrosarcoma (HT-1080) and neuroblastoma (SK-N-BE) tumour cells (data not shown). This evidence concerns the gene MMP9 and fibrosarcoma.